Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Vaccine|February 15, 2018
Safety and tolerability of a liquid bovine rotavirus pentavalent vaccine (LBRV-PV) in adultsK Anil, Sajjad Desai, Chetanraj Bhamare, et al.
Vaccine: X|August 18, 2023
Post-marketing safety surveillance of the rotavirus vaccine in IndiaGagandeep Kang, Anand Lakhkar, Chetanraj Bhamare, et al.
NPJ Vaccines|December 19, 2022
A phase I clinical study to assess safety and immunogenicity of yellow fever vaccineSajjad Desai, K Anil, Anirudha Vyankatesh Potey, et al.
The Lancet. Infectious Diseases|June 30, 2022
Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trialMark F Cotton, Shabir A Madhi, Angelique K Luabeya, et al.
Vaccine|October 3, 2017
A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infantsPrasad S Kulkarni, Sajjad Desai, Tushar Tewari, et al.
Vaccine|November 14, 2018
A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infantsNiraj Rathi, Sajjad Desai, Anand Kawade, et al.
Vaccine|April 9, 2019
Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infantsAnand Kawade, Sudhir Babji, Veena Kamath, et al.
Vaccine|August 15, 2018
Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccineSajjad Desai, Niraj Rathi, Anand Kawade, et al.
Pageof 1